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| INTRODUC TI ON
Bone marrow (BM) study including aspiration and biopsy is a wellestablished diagnostic procedure and is regarded as the standard for staging lymphoma patients. In some various clinical situations, BM biopsy may be the least invasive method or the only means of obtaining samples for the classification of lymphoma. Differential diagnoses can be made by BM using the morphologic and immunohistochemical (IHC) criteria used for lymph nodes biopsies, 1 
Hydroa vacciniforme-like lymphoproliferative disorder such as flow cytometry and IHC stain using lymph node infiltrates or extranodal specimens, have been used to define lymphoma subtypes. On the other hand, the diagnostic value of BM alone for the differential diagnosis of lymphoma has not been actively studied. In the present study, the utility of BM studies for the classification of lymphoma was investigated. Cases in which a BM was used for initial investigative specimens in lymphoma were analyzed, and cases in which a primary diagnosis of lymphoma made by BM study with or without following tissue biopsy were reviewed. BM lymphoma involvement ratios and the proportion of lymphomas staged by BM studies among all BM studies conducted throughout 11 years, and the incidence and BM involvement patterns of malignant lymphoma types were also reviewed. terns. CLL exhibited both diffuse interstitial (40%) and diffuse solid (40%) patterns. BL predominantly adopted the diffuse solid pattern (55.6%). For T-and NK-cell lymphomas, PTCL mainly presented the diffuse interstitial pattern (33.3%), whereas AITL favored the focal non-paratrabecular (33.3%) and diffuse interstitial (33.3%) patterns. Table 3 presents annual BM study numbers, proportions of lymphoma evaluations, and types of initial investigation specimens.
| ME THODS

| Initial evaluation of lymphoma by bone marrow study
BM cases increased during the study period (Spearman's correlation 0.836, P-value <0.05), but no significant change was observed in the annual proportion of lymphoma cases evaluated (P-value >0.05). However, BM study cases for initial evaluation of malignant lymphoma did eventually increase during the study period (P = 0.019), for example, nine cases (17.3%) in 2006 and 38 cases (24.4%) in 2016 (Table 1, Figure 2 ). In cases first evaluated for lymphoma by BM study, 108 (42.4%) of 255 cases showed lymphoma BM involvement. Sixty-six cases (61.1%) underwent tissue biopsy after BM study.
F I G U R E 1 Proportion of involvement patterns by type of lymphoma
Types of lymphoma, concordance with lymph node biopsy, and BM involvement patterns are detailed in between tissue biopsy and BM biopsy were confirmed for three patients ( Table 5 ). One patient with monoclonal protein and en- 
| D ISCUSS I ON
Malignant lymphoma is typically diagnosed and classified using tissue biopsies, such as lymph node biopsies. The incidence of lymphoma in the United States has steeply increased from the 1980 to 2000s. 3 Nowadays as increasing lymphoma cases, diagnosis of lymphoma is diagnosed using tissue and BM biopsies. In this study, we investigated the incidences of lymphomas classified in accord with the WHO classification scheme and marrow lymphoma involvement frequencies and patterns and also investigated the utility of BM study as an initial diagnostic specimen of malignant lymphoma.
The American Society of Clinical Oncology has made a recommendation regarding the initial evaluation and staging of lymphoma. 4 According to their recommendations, excisional biopsy is preferred to obtain adequate tissue for diagnosis, and that core-needle biopsy is considered when an excisional biopsy is not possible. Regarding lymphoma staging, BM biopsy is still regarded as the standard.
However, many noninvasive procedures, such as radiologic examinations, have been studied for use in define BM involvement. In a recent study, it was suggested a BM study is not required for routine CT scan is negative. 4, 5 In another study, it was suggested BM biopsy could provide information in addition to BM involvement, such as information on the hematologic status of patients. 9 The present study shows a trend toward the initial diagnosis of lymphoma using BM specimens, which suggests BM biopsy is likely to remain an essential tool for the diagnosis and staging of lymphoma.
The total number of BM cases increased over the 11-year study period, but the proportion of BM study for lymphoma evaluation did not increase significantly. Nevertheless, the absolute number of lymphoma evaluation of BM study cases was increased as increasing total number of BM study. The purpose of BM study in lymphoma patients was disease staging in most of our cases.
Many studies have been conducted on the prevalence of malignant lymphoma types and rates of bone marrow involvement. In the present study, most lymphoma cases were NHL, and DLBCL was the most common lymphoma type of NHL, followed by MALT, MCL, and CLL. DLBCL was the most common lymphoma in another study conducted in a Spanish university hospital, an institute in Taiwan, and a report issued in North China. However, the second most common type differed among the studies. 10, 11 The present study found BM involvement frequencies in some lymphoma types differ from previous reports. BL involvement had the second highest frequency (70%); however, involvement rates were much lower (1.8%-35%) in previous reports, and in case of T-cell lymphoma, the incidence of AITL is lower than other studies (>50%). 13, 14 According to a study conducted by Stanford University, in which lymphoma incidence from 1992 to 2001 was reviewed, follicular lymphoma showed BM and North China found DLBCL showed the highest BM involvement incidence. In the present study, which was performed in our institution for over 11 years, DLBCL was the most common, followed by MALT, MCL, and CLL.
Lymphoma has characteristic bone marrow involvement patterns, and thus, hematologists can predict lymphoma types based on lymphoma cell morphology and these involvement patterns by H&E staining without IHC staining. Focal non-paratrabecular type in CLL/SLL, focal paratrabecular type in FL, intrasinusoidal type in SML, and diffuse interstitial type in BL are well-known favored involvement patterns of these lymphomas. 13, 14 In the present study, involvement patterns well matched those described in previous studies, except for CLL/SLL. In previous studies, CLL/SLL favored a diffuse interstitial and focal non-paratrabecular pattern, 12, 15, 16 whereas in the present study, it favored diffuse interstitial and diffuse solid patterns.
The number of BM studies for lymphoma evaluations increased from 49 to 156 cases over the 11-year study period, and the proportion of BM studies as initial investigative specimens also increased.
After lymphoma evaluation in BM study, about 61.1% of cases performed lymph node biopsies. When lymphoma was identifiable in BM study, overall concordance between BM and lymph node biopsy diagnosis was 84.85% (56 of 66 cases). B-cell lymphoma cases were more concordant between the two samples than T-cell lymphoma cases (88.89% vs 70.59%). Thomas Buhr et al 18 have previously reported a concordance rate of BM and lymph node biopsy in 124 patient was 91% in all types of lymphoma. Likewise in our study, the concordance rate of those was high (84.85%).
Among the 66 cases where additional tissue biopsy was per- other additional studies and morphologic features. Although additional analysis does not always provide useful results, these studies can provide critical information for the differential diagnosis of lymphoma. The preferred BM involvement patterns of different malignant lymphoma types are well known, and thus, BM involvement patterns can give diagnostic clues, as in tissue biopsies.
In summary, this study shows initial investigations of malignant lymphoma using BM specimens increased during the period 2006-2016, which demonstrates the growing importance of BM study as an investigative tool for malignant lymphoma. Although not all lymphoma involves BM, BM study which has high concordance rate with lymph node biopsy can be an acceptable choice for diagnosing lymphoma.
Furthermore, combined with morphological feature and involvement pattern from BM biopsy and additional laboratory tests, such as flow cytometry, chromosomal study, FISH analysis, and clinical information, BM study offers a powerful means of diagnosing lymphoma.
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